The inventors have developed various devices, including in one embodiment, an inexpensive hand held device that can measure a wide range of HFA-134a levels in human breath. The present invention is also directed to a kit for detection of one or more halogenated organic compounds. The kit is useful for practicing the inventive method of measuring asthma inhaler compliance, for example.
Asthma inhalers, such as inhaled corticosteroids and bronchodilators, are the first line of asthma treatment. However, one problem facing clinicians and researchers has been the lack of technologies to measure treatment compliance and/or efficacy. Currently the typical methods to measure ICS or bronchodilator compliance include patient self-report of medication use and medication canister weighing or counting actuations. However, these current solutions are not optimal for both adults and children. Patient self-report of asthma inhaler use is notoriously inaccurate. Other advanced methods such as electronic monitoring of inhaled medication compliance are limited because it will not be able to detect whether the medication is actually inhaled. There is no readily accessible method available to identify asthma inhaler compliance or treatment efficacy. Thus, there is a need in the art for novel and effective methods and devices for identifying asthma inhaler compliance and treatment efficacy.
Some embodiments are configured for the purpose of treating asthma. In one embodiment, the kit is configured particularly for the purpose of treating mammalian subjects. In another embodiment, the kit is configured particularly for the purpose of treating human subjects. In further embodiments, the kit is configured for veterinary applications, treating subjects such as, but not limited to, farm animals, domestic animals, and laboratory animals.
Prototype in development